National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011

S. 2037, Discussed reauthorization of the Older Americans Act and various proposals (112th Congress). S. 462, Elder Abuse Victims Act of 2011 - Continued advocacy to develop legislative and regulatory policy to protect seniors from abuse, exploitation and neglect.H.R.2883/S. 1542 (112th Congress), Child and Family Services Improvement and Innovation Act - Discussed provisions supporting grandparents raising grandkids. S. 465, Senior Financial Empowerment Act of 2011 - Continued advocacy to develop legislative and regulatory policy to protect seniors from abuse, exploitation and neglect. S. 464, Elder Abuse in Later Life Act of 2011 - Continued advocacy to develop legislative and regulatory policy to protect seniors from abuse, exploitation and neglect. S.2077/H.R. 866, Elder Abuse Prevention Act (112th Congress) - Continued advocacy to develop legislative and regulatory policy to protect seniors from abuse, exploitation and neglect. S. 1263/H.R. 112, Silver Alert Act - Discussed elder abuse issues of 2011. S. 2037, Older Americans Act Amendments of 2012 - Discussed legislation. S. 1744, Guardian Accountability and Senior Protection Act - Supported legislation (112th Congress). S. 1982, Improving Care for Vulnerable Older Citizens through Workforce Advancement Act of 2011 - Discussed legislation. Discussed elder abuse issues, ARDC's and the World Elder Abuse Awareness Day. S.3358, Responding to urgent needs of survivors of the Holocaust Act - Discussed the improvement of services under OAA. Discussed legislation on Guardianship and Elder Abuse Prevention. (no bill) S. 1284, Labor, Health and Human Services Appropriations, 2014 - Lobbied to protect funding levels for Older Americans Act programs. S. 1028, OAA Reauthorization - Advocated adoption of a simple OAA reauthorization bill. Discussed House OAA Reauthorization by advocating adoption of simple OAA reauthorization bill. (no bill) Discussed necessary changes to Caregiver bill amending OAA. (no bill) S. 975, Court Appointed Guardian Accountability Act - Discussed necessary changes to bill. Discussed Seniors Fraud Protection Act (H.R. 1953/S. 1358) and Elder Protection and Abuse Prevention Act (S. 1019) and health care scams. Discussed support of compromise Senate OAA requthorization bill by HELP Committee Leadership. (no bill) Discussed support of S. 1358, Seniors Fraud Prevention Act of 2013.

Client expense: $2,520,000 · Firm income: Not reported

Government targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Council on Disability, Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office

S. 2037, Discussed reauthorization of the Older Americans Act and various proposals (112th Congress). S. 462, Elder Abuse Victims Act of 2011 - Continued advocacy to develop legislative and regulatory policy to protect seniors from abuse, exploitation and neglect.H.R.2883/S. 1542 (112th Congress), Child and Family Services Improvement and Innovation Act - Discussed provisions supporting grandparents raising grandkids. S. 465, Senior Financial Empowerment Act of 2011 - Continued advocacy to develop legislative and regulatory policy to protect seniors from abuse, exploitation and neglect. S. 464, Elder Abuse in Later Life Act of 2011 - Continued advocacy to develop legislative and regulatory policy to protect seniors from abuse, exploitation and neglect. S.2077/H.R. 866, Elder Abuse Prevention Act (112th Congress) - Continued advocacy to develop legislative and regulatory policy to protect seniors from abuse, exploitation and neglect. S. 1263/H.R. 112, Silver Alert Act - Discussed elder abuse issues of 2011. S. 2037, Older Americans Act Amendments of 2012 - Discussed legislation. S. 1744, Guardian Accountability and Senior Protection Act - Supported legislation (112th Congress). S. 1982, Improving Care for Vulnerable Older Citizens through Workforce Advancement Act of 2011 - Discussed legislation. Discussed elder abuse issues, ARDC's and the World Elder Abuse Awareness Day. S.3358, Responding to urgent needs of survivors of the Holocaust Act - Discussed the improvement of services under OAA. Discussed legislation on Guardianship and Elder Abuse Prevention. (no bill) H.R. 803, Skills Act - Discussed WIA Reauthorization and Older Workers. Labor, Health and Human Services Appropriations, 2014 - Lobbied to protect funding levels for Older Americans Act programs. (no bill) S. 1028, OAA Reauthorization - Advocated adoption of a simple OAA reauthorization bill. Discussed House OAA Reauthorization by advocating adoption of simple OAA reauthorization bill. (no bill) Discussed necessary changes to Caregiver bill amending OAA. (no bill) S. 975, Court Appointed Guardian Accountability Act - Discussed necessary changes to bill.

Client expense: $2,460,000 · Firm income: Not reported

Government targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Council on Disability, Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office

S. 2037, Discussed reauthorization of the Older Americans Act and various proposals (112th Congress). S. 462, Elder Abuse Victims Act of 2011 - Continued advocacy to develop legislative and regulatory policy to protect seniors from abuse, exploitation and neglect.H.R.2883/S. 1542 (112th Congress), Child and Family Services Improvement and Innovation Act - Discussed provisions supporting grandparents raising grandkids. S. 465, Senior Financial Empowerment Act of 2011 - Continued advocacy to develop legislative and regulatory policy to protect seniors from abuse, exploitation and neglect. S. 464, Elder Abuse in Later Life Act of 2011 - Continued advocacy to develop legislative and regulatory policy to protect seniors from abuse, exploitation and neglect. S.2077/H.R. 866, Elder Abuse Prevention Act (112th Congress) - Continued advocacy to develop legislative and regulatory policy to protect seniors from abuse, exploitation and neglect. S. 1263/H.R. 112, Silver Alert Act - Discussed elder abuse issues of 2011. S. 1819, Strengthening Services for America's Seniors Act - Discussed legislation (112th Congress). S. 2037, Older Americans Act Amendments of 2012 - Discussed legislation. S. 1744, Guardian Accountability and Senior Protection Act - Supported legislation (112th Congress). S. 1982, Improving Care for Vulnerable Older Citizens through Workforce Advancement Act of 2011 - Discussed legislation. Discussed elder abuse issues, ARDC's and the World Elder Abuse Awareness Day. S.3358, Responding to urgent needs of survivors of the Holocaust Act - Discussed the improvement of services under OAA. Discussed legislation on Guardianship and Elder Abuse Prevention. (no bill) H.R. 803, Skills Act - Discussed WIA Reauthorization and Older Workers.

Client expense: $2,130,000 · Firm income: Not reported

Government targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Council on Disability, Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office

S. 3430, National Diabetes Clinical Care Commission Act, all provisions S. 1560, Nursing Home Resident Pain Relief Act of 2011, all provisions H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization (NASPER) Act of 2011, all provisions H.R. 2119, Ryan Creedon Act of 2011, all provisions Prescription Drug Diversion Prescription Drug Abuse Combating Prescription Drug Overdose Drug Shortages Personalized Medicine Quality Measure Funding Prevention Fund Flexible Spending Accounts (FSAs) Uniform electronic prior authorization process ICD-10 Repeal Procedural Coding EHR - Meaningful Use program Health Information Technology Clinical data registries Compounding Pharmacy Oversight Payment and Delivery Reform Health Insurance Reform Gun Violence Insurance Exchanges Plan B Emergency Contraception Hospital Readmission Common Format ACA Non-Discrimination Provision

Client expense: $3,400,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA), White House Office

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827, To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. H.R. 8, American Taxpayer Relief Act of 2012. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827, To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. H.R. 8, American Taxpayer Relief Act of 2012. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827, To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. H.R. 8, American Taxpayer Relief Act of 2012. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827, To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. H.R. 8, American Taxpayer Relief Act of 2012. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011 H.R. 1266, Fraudulent Prescription Prevention Act of 2011 H.R. 1925, Prescription Drug Abuse Prevention and Treatment Act of 2011 S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011 S. 882, STOP Act S.968, Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 S. 1002, Safe Doses Act S. 1612, Targeting Transnational Drug Trafficking Act of 2011

Client expense: $440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE

H.R. 451, Healthcare Truth and Transparency Act: Healthcare Provider Transparency, Healthcare Provider Misrepresentation H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act S. 296/H.R. 2245, Preserving Access to Life-saving Medications Act, drug shortages S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011 H.R. 2119, Ryan Creedon Act of 2011 Medical Liability Reform; H.R. 5, HEALTH Act of 2011 H.R. 3839, Drug Shortage Prevention Act of 2012 H.R. 2245, Preserving Access to Life-saving Medications Act of 2011 P.L. 112-144, The Food and Drug Administration Safety and Innovation Act Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee PPACA Nondiscrimination language regarding paraprofessionals - repeal DEA Scheduling Propofol Comparative Effectiveness Research HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Risk Evaluation and Mitigation Strategies FDA Safe Use Initiative Pain Management Individual Mandate- PPACA Proposed Federal CME requirements by ONDCP FTC Letters to States regarding Interventional Pain Medicine and Advanced Practice Nurses Scope of Practice FDA Operating Room Fires Prescription Drug User Fee Act State Exchanges pursuant to PPACA FDA SEDASYS FDA Patient Prescriber working group FDA Sedation Initiative FDA Naloxone workshop FDA Patient Prescriber Agreement workshop FDA Anesthesia Trials workshop FDA Opioid Efficacy workshop ICD-10-CM/PCS and proposed delay of implementation date

Client expense: $230,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE

**see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297) Drug Abuse (S. 507) Drug Shortages (S. 296/H.R. 2245/H.R. 3839/PL 112-144/H.R. 5853/H.R. 5651) Rx Pedigree (H.R. 3026/PL 112-144) Cargo/Product Theft (S. 1002/H.R. 4223) Prescription Drug Monitoring Program (H.R. 2254/H.R. 4292/PL 112-144) Counterfeit Drugs (S. 1886/H.R. 3668/PL 112-144) ***, no specific bills, supply chain integrity, prescription drug abuse

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R.866-National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act of 2011 H.R.1065- Pill Mill Crackdown Act of 2011 H.R.1254-Synthetic Drug Control Act of 2011 H.R.1571-Combating Dangerous Synthetic Stimulants Act of 2011 H.R.2245-Preserving Access to Life-Saving Medications Act of 2011 H.R.3668-Counterfeit Drug Penalty Enhancement Act of 2012 H.R.5651-Food and Drug Administration Safety and Innovation Act S.296-Preserving Access to Life-Saving Medications Act S.409-Combating Dangerous Synthetic Stimulants Act of 2011 S.605-Dangerous Synthetic Drug Control Act of 2011 S.839-Combating Designer Drugs Act of 2011 S.1760-Pill Mill Crackdown Act of 2011 S.2516-Food and Drug Administration Safety and Innovation Act S.3187-Food and Drug Administration Safety and Innovation Act

Client expense: $695,377 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Rx Pedigree (H.R. 3026/PL 112-144); NASPER Reauthorization (H.R. 866); Prescription Drug Monitoring Programs (S. 2254/H.R. 4292/PL 112-144); Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297); Drug Abuse (S. 507); Drug Shortages (S. 296/HR 2245/HR 3839/ PL 112-144/HR 5853/HR 5651); Cargo/Product Theft (S. 1002/H.R. 4223; PL 112-204); Counterfeit Drugs (S. 1886/H.R. 3668/PL 112-144)

Client expense: $228,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827,To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827,To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827,To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827,To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE

**see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297) Drug Abuse (S. 507) Drug Shortages (S. 296/H.R. 2245/H.R. 3839/S.3187/H.R. 5853/H.R. 5651) Rx Pedigree (H.R. 3026/S. 3187) Cargo/Product Theft (S. 1002/H.R. 4223) Prescription Drug Monitoring Program (H.R. 2254/H.R. 4292/S. 3187) Counterfeit Drugs (S. 1886/H.R. 3668/S. 3187) ***, no specific bills, supply chain integrity, prescription drug abuse

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

S. 3187, Food and Drug Administration Safety and Innovation Act, provisions relating to drug shortages, antibiotic incentives, and combating diversion H.R. 5998, USPSTF Transparency and Accountability Act of 2012, all provisions H.R. 2119, Ryan Creedon Act of 2011, all provisions H.R. 3497, MODDERN Cures Act of 2011, all provisions H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011, all provisions H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011, all provisions H.R. 2182, Generating Antibiotic Incentives Now Act of 2011, all provisions H.R. 2960, National Diabetes Clinical Care Commission Act, all provisions H.R. 4384, Patient Safety and Drug Labeling Improvement Act, all provisions Clinical Registries ACA Implementation Insurance Exchanges Prescription Drug Abuse Drug diversion/mandatory CME for DEA Registrants/violence prevention Drug shortages Flexible Spending Accounts (FSAs) Delivery and Payment Reform Personalized Medicine Health Information Technology HIPAA Administrative Simplifications Health Insurance Reform Medical Licensing Boards and Scope of Practice

Client expense: $3,680,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office

H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011 H.R. 1266, Fraudulent Prescription Prevention Act of 2011 H.R. 1925, Prescription Drug Abuse Prevention and Treatment Act of 2011 S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011 S. 882, STOP Act S.968, Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 S. 1002, Safe Doses Act S. 1612, Targeting Transnational Drug Trafficking Act of 2011

Client expense: $440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE

H.R. 451, Healthcare Truth and Transparency Act: Healthcare Provider Transparency, Healthcare Provider Misrepresentation H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act S. 296/H.R. 2245, Preserving Access to Life-saving Medications Act, drug shortages S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011 H.R. 2119, Ryan Creedon Act of 2011 Medical Liability Reform; H.R. 5, HEALTH Act of 2011 H.R. 3839, Drug Shortage Prevention Act of 2012 H.R. 2245, Preserving Access to Life-saving Medications Act of 2011 P.L. 112-144, The Food and Drug Administration Safety and Innovation Act Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee PPACA Nondiscrimination language regarding paraprofessionals - repeal DEA Scheduling Propofol Comparative Effectiveness Research HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Risk Evaluation and Mitigation Strategies FDA Safe Use Initiative Pain Management Individual Mandate- PPACA Proposed Federal CME requirements by ONDCP FTC Letters to States regarding Interventional Pain Medicine and Advanced Practice Nurses Scope of Practice FDA Operating Room Fires Prescription Drug User Fee Act State Exchanges pursuant to PPACA FDA SEDASYS FDA Patient Prescriber working group FDA Sedation Initiative FDA Naloxone workshop FDA Patient Prescriber Agreement workshop FDA Anesthesia Trials workshop FDA Opioid Efficacy workshop ICD-10-CM/PCS and proposed delay of implementation date

Client expense: $120,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE

H.R.866-National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act of 2011 H.R.1065- Pill Mill Crackdown Act of 2011 H.R.1254-Synthetic Drug Control Act of 2011 H.R.1571-Combating Dangerous Synthetic Stimulants Act of 2011 H.R.2245-Preserving Access to Life-Saving Medications Act of 2011 H.R.3668-Counterfeit Drug Penalty Enhancement Act of 2012 H.R.5651-Food and Drug Administration Safety and Innovation Act S.296-Preserving Access to Life-Saving Medications Act S.409-Combating Dangerous Synthetic Stimulants Act of 2011 S.605-Dangerous Synthetic Drug Control Act of 2011 S.839-Combating Designer Drugs Act of 2011 S.1760-Pill Mill Crackdown Act of 2011 S.2516-Food and Drug Administration Safety and Innovation Act S.3187-Food and Drug Administration Safety and Innovation Act

Client expense: $433,244 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Rx Pedigree (H.R. 3026/S. 3187); NASPER Reauthorization (H.R. 866); Prescription Drug Monitoring Programs (S. 2254/H.R. 4292/S.3187); Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297); Drug Abuse (S. 507); Drug Shortages (S. 296/ H.R. 2245/H.R. 3839/S. 3187/H.R. 5853/H.R. 5651); Cargo/Product Theft (S. 1002/H.R. 4223); Counterfeit Drugs (S. 1886/H.R. 3668/S. 3187)

Client expense: $222,819 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 2182, Generating Antibiotic Incentives Now Act of 2011, all provisions S. 1734, Generating Antibiotic Incentives Now Act of 2011, all provisions H.R. 4095, Online Pharmacy Safety Act, all provisions S. 2002, Online Pharmacy Safety Act, all provisions H.R. 2245, Preserving Access to Life-Saving Medications Act of 2011, all provisions S. 296, Preserving Access to Life-Saving Medications Act, all provisions H.R. 2086, Medical Debt Responsibility Act of 2011, all provisions S. 2149, Medical Debt Responsibility Act of 2012, all provisions H.R. 5651, Food and Drug Administration Reform Act of 2012, all provisions S. 3187, Food and Drug Administration Safety and Innovation Act, all provisions H.R. 2960, National Diabetes Clinical Care Commission Act, all provisions S. 2295, Patient Safety and Generic Labeling Improvement Act , all provisions H.R. 2119, Ryan Creedon Act of 2011, all provisions H.R. 3497, MODDERN Cures Act of 2011, all provisions H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011, all provisions H.R. 2939, Pharmaceutical Stewardship Act of 2011, all provisions H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011, all provisions H.R. 3839, Drug Shortage Prevention Act of 2012, all provisions H.R. 5842, Restoring Access to Medication Act of 2012, all provisions S.Amdt. 2151, To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug Mandatory CME for DEA Registrants Bath Salts Tanning Beds Affordable Care Act Insurance exchanges Violence Against Women Act, provisions relating to quality Drug Shortages Prescription Drug Abuse Next generation antibiotics Scope of Practice Health Insurance Reform Health Information Technology Flexible Spending Accounts/OTC medications Tax deduction for physician charity care HIPAA Administrative Simplification HIPAA privacy and security standards Regulation of energy beverages Unique Device Identification System Multi-Payor Claims Database Private payer guidelines for reporting data to physicians

Client expense: $4,400,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011 H.R. 1266, Fraudulent Prescription Prevention Act of 2011 H.R. 1925, Prescription Drug Abuse Prevention and Treatment Act of 2011 S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011 S. 882, STOP Act S.968, Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 S. 1002, Safe Doses Act S. 1612, Targeting Transnational Drug Trafficking Act of 2011

Client expense: $560,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827,To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 5651, Food and Drug Administration Reform Act of 2012. Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827,To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 5651, Food and Drug Administration Reform Act of 2012. Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827,To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 5651, Food and Drug Administration Reform Act of 2012. Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827,To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 5651, Food and Drug Administration Reform Act of 2012. Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 451, Healthcare Truth and Transparency Act: Healthcare Provider Transparency, Healthcare Provider Misrepresentation H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act S. 296/H.R. 2245, Preserving Access to Life-saving Medications Act, drug shortages S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011 H.R. 2119, Ryan Creedon Act of 2011 Medical Liability Reform; H.R. 5, HEALTH Act of 2011 H.R. 3839, Drug Shortage Prevention Act of 2012 H.R. 2245, Preserving Access to Life-saving Medications Act of 2011 P.L. 112-144, The Food and Drug Administration Safety and Innovation Act Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee PPACA Nondiscrimination language regarding paraprofessionals - repeal DEA Scheduling Propofol Comparative Effectiveness Research HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Risk Evaluation and Mitigation Strategies FDA Safe Use Initiative Pain Management Individual Mandate- PPACA Proposed Federal CME requirements by ONDCP FTC Letters to States regarding Interventional Pain Medicine and Advanced Practice Nurses Scope of Practice FDA Operating Room Fires Prescription Drug User Fee Act State Exchanges pursuant to PPACA FDA SEDASYS FDA Patient Prescriber working group FDA Sedation Initiative FDA Naloxone workshop FDA Patient Prescriber Agreement workshop FDA Anesthesia Trials workshop FDA Opioid Efficacy workshop ICD-10-CM/PCS and proposed delay of implementation date

Client expense: $280,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE

**see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297) Drug Abuse (S. 507) Drug Shortages (S. 296/H.R. 2245/H.R. 3839/S.3187/H.R. 5853/H.R. 5651) Rx Pedigree (H.R. 3026/S. 3187) Cargo/Product Theft (S. 1002/H.R. 4223) Import Safety (S. 1584) Drug Importation (H.R. 2112 - Agriculture, Transportation Appropriations Bill for 2012) Prescription Drug Monitoring Program (H.R. 2254/H.R. 4292/S. 3187) Counterfeit Drugs (S. 1886/H.R. 3668/S. 3187) Internet Pharmacey (S. 2002/H.R. 4095) ***, no specific bills: supply chain integrity, prescription drug abuse, internet pharmacy regulation

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Drug shortages - Proposed legislation re these issues. Opiate abuse - HR 1316, Stop Oxy Abuse Act of 2011; HR 2119, Ryan Creedon Act of 2011; HR 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011; HR 1065, Pill Mill Crackdown Act of 2011; S 507, Prescription Drug Abuse Prevention and Treatment Act of 2011; Executive Branch action re this issue. Pharmaceutical issues, including tracking and tracing medicines, fostering competition between generic and brand-name pharmaceutical manufacturers - HR 5651, Food and Drug Administration Reform Act of 2012; S 3187, Food and Drug Administration Safety and Innovation Act. Incentives to develop antibiotics - HR 2182, Generating Antibiotic Incentives Now Act of 2011; S 1734, Generating Antibiotic Incentives Now Act of 2011. Establish criminal penalties for trafficking in counterfeit drugs - HR 3468, Counterfeit Drug Penalty Enhancement Act of 2011; S 1886, Counterfeit Drug Penalty Enhancement Act of 2011. National Center for Advancing Transformational Sciences at FDA; agreement to review compounds for potential new uses - Executive Branch actions re these issues. *Follow-on biologics generally. *Certified Importer Program. *Drug safety - HR 1483, Drug Safety Enhancement Act of 2011.

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; H.R. 5651 & S. 2516 & S.3187 to drug shortages

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Importation of Prescription Drugs (S. 319, H.R. 147); Rx Pedigree (H.R. 3026/S. 3187); NASPER Reauthorization (H.R. 866); Presecription Drug Monitoring Programs (S. 2254/H.R. 4292/S. 3187); Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297); Drug Abuse (S. 507); Drug Shortages (S. 296/ H.R. 2245/H.R. 3839/S. 3187/H.R. 5853/H.R. 5651); Cargo/Product Theft (S.1002/H.R. 4223); Import Safety(S.1584); Counterfeit Drugs(S.1886/H.R. 3668/S.3187); Internet Pharmacy(S.2002/H.R. 4095)

Client expense: $323,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

**see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760) Drug Abuse (S. 507) Drug Stortages (S. 296/H.R. 2245/H.R. 3839) Rx Pedigree (H.R. 3026) Cargo/Product Theft (S. 1002/H.R. 4223) Import Safety (S. 1584) Drug Importation (H.R. 2112 - Agriculture, Transportation Appropriations Bill for 2012) Prescription Drug Monitoring Program (H.R. 2254/H.R. 4292) Counterfeit Drugs (S. 1886/H.R. 3668) Internet Pharmacey (S. 2002/H.R. 4095) ***, no specific bills, federal pedigree, import safety

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 2119, Ryan Creedon Act of 2011, all provisions H.R. 3497, MODDERN Cures Act of 2011, all provisions H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011, all provisions H.R. 866, National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act of 2011, all provisions H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011, all provisions S. 1734, Generating Antibiotic Incentives Now (GAIN) Act of 2011, all provisions H.R. 2245, Preserving Access to Life-Saving Medications Act of 2011, all provisions S. 296, Preserving Access to Life-Saving Medications Act, all provisions H.R. 2086, Medical Debt Responsibility Act of 2011, all provisions S. 2149, Medical Debt Responsibility Act of 2012, all provisions H.R. 4095, Online Pharmacy Safety Act, all provisions S. 2002, Online Pharmacy Safety Act, all provisions H.R. 2529, Restoring Access to Medication Act, all provisions S. 1368, Restoring Access to Medication Act, all provisions H.R. 2939, Pharmaceutical Stewardship Act of 2011, all provisions S. 2096, Federal Research Public Access Act of 2012, all provisions Patient Safety and Generic Label Improvement Act draft bill, all provisions Affordable Care Act Transparency Reporting/Sunshine Act Regulations Prescription Drug User Fee Act (PDUFA) Medical Licensing Boards and Scope of Practice Drug Shortages Combating prescription drug diversion Flexible Spending Accounts Antibiotics and drug resistant pathogens Comparative Effectiveness Research Physician Education - HIPAA privacy protections Over-the-Counter Medicine WHO data collection International health and chronic disease Shared Savings/Accountable Care Organizations Health Insurance Reform Healthcare Delivery and Payment Reform All payer all claims databases Definition of a Fact Box ICD-10 Stand for Quality Coalition Health Information Technology Scope of Practice

Client expense: $4,650,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), Office of Natl Drug Control Policy (NDCP), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827,To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) Monitor appropriations process and federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827,To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor appropriations process and federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827,To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) Monitor appropriations process and federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 452, Medicare Decisions Accountability Act of 2011. H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011. H.R. 3827,To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding. Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) Monitor appropriations process and federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER), (P.L. 109-60).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 451, Healthcare Truth and Transparency Act: Healthcare Provider Transparency, Healthcare Provider Misrepresentation H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act S. 296/H.R. 2245, Preserving Access to Life-saving Medications Act, drug shortages S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011 H.R. 2119, Ryan Creedon Act of 2011 Medical Liability Reform; H.R. 5, HEALTH Act of 2011 H.R. 3839, Drug Shortage Prevention Act of 2012 H.R. 2245, Preserving Access to Life-saving Medications Act of 2011 FTC Letters to States regarding Interventional Pain Medicine and Advanced Practice Nurses Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee PPACA Nondiscrimination language regarding paraprofessionals - repeal DEA Scheduling Propofol Comparative Effectiveness Research HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Risk Evaluation and Mitigation Strategies FDA Safe Use Initiative Pain Management Individual Mandate- PPACA Proposed Federal CME requirements by ONDCP FDA Sedation Initiative Scope of Practice FDA Operating Room Fires FDA Sentinel Prescription Drug User Fee Act NASPER Funding; controlled substance abuse, misuse and diversion State Exchanges pursuant to PPACA FDA SEDASYS FDA Patient Prescriber working group Senator Tom Udall national licensing draft legislation

Client expense: $240,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE

Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; H.R 2245, H.R. 3839 S. 296 Related to Drug Shortages S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011 H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 H.R. 4233 & S. 1002 - Safe Doses Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1886 & H.R. 3668 - Counterfeit Drug Penalty Enhancement Act of 2011 S. 2002 & H.R. 4095 - Online Pharmacy Safety Act

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; H.R 2245, H.R. 3839 S. 296 Related to Drug Shortages S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011 H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 H.R. 4233 & S. 1002 - Safe Doses Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1886 & H.R. 3668 - Counterfeit Drug Penalty Enhancement Act of 2011 S. 2002 & H.R. 4095 - Online Pharmacy Safety Act

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011 H.R.1266, Fraudulent Prescription Prevention Act of 2011 H.R.1925, Prescription Drug Abuse Prevention and Treatment Act of 2011 S.507, Prescription Drug Abuse Prevention and Treatment Act of 2011 S.882, STOP Act S.968, Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 S.1002, Safe Doses Act S.1612, Targeting Transnational Drug Trafficking Act of 2011

Client expense: $560,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE

Importation of Presceiption Drugs (S. 319, H.R. 147); Rx Pedigree (H.R. 3026/draft PDUFA legislation); NASPER Reauthorization (H.R. 866); Prescription Drug Monitoring Programs (S. 2254/H.R. 4292); Pill Mill Crackdown Act (H.R. 1065/S. 1760); Drug Abuse (S. 507); Drug Shortages (S. 296/H.R. 2245/H.R. 3839/draft PDUFA legislation); Cargo/Product Theft (S. 1002/H.R. 4223); Import Safety (S. 1584); Counterfeit Drugs (S. 1886/H.R. 3668); Internet Pharmacy (S. 2002/H.R. 4095)

Client expense: $282,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE